Bueren JA - Search Results

1

Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.

Yañez R, Oviedo A, Aldea M, Bueren JA, Lamana ML. Yañez R, et al. Among authors: bueren ja. Exp Cell Res. 2010 Nov 15;316(19):3109-23. doi: 10.1016/j.yexcr.2010.08.008. Epub 2010 Sep 8. Exp Cell Res. 2010. PMID: 20804749

2

Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.

Guenechea G, Segovia JC, Albella B, Lamana M, Ramírez M, Regidor C, Fernández MN, Bueren JA. Guenechea G, et al. Among authors: bueren ja. Blood. 1999 Feb 1;93(3):1097-105. Blood. 1999. PMID: 9920860 Free article.

3

Conclusions of a national multicenter intercomparative study of in vitro cultures of human hematopoietic progenitors.

Lamana M, Albella B, Rodríguez F, Regidor C, Bueren JA. Lamana M, et al. Among authors: bueren ja. Bone Marrow Transplant. 1999 Feb;23(4):373-80. doi: 10.1038/sj.bmt.1701577. Bone Marrow Transplant. 1999. PMID: 10100581

4

Systematic analysis of clinically applicable conditions leading to a high efficiency of transduction and transgene expression in human T cells.

Lamana ML, Segovia JC, Guenechea G, Bueren JA. Lamana ML, et al. Among authors: bueren ja. J Gene Med. 2001 Jan-Feb;3(1):32-41. doi: 10.1002/1521-2254(2000)9999:9999<::AID-JGM153>3.0.CO;2-R. J Gene Med. 2001. PMID: 11269334

5

In vitro and in vivo susceptibility of mouse megakaryocytic progenitors to strain i of parvovirus minute virus of mice.

Lamana ML, Albella B, Bueren JA, Segovia JC. Lamana ML, et al. Among authors: bueren ja. Exp Hematol. 2001 Nov;29(11):1303-9. doi: 10.1016/s0301-472x(01)00724-x. Exp Hematol. 2001. PMID: 11698126 Free article.

6

Functional and phenotypic variations in human T cells subjected to retroviral-mediated gene transfer.

Lamana ML, Bueren JA, Vicario JL, Balas A. Lamana ML, et al. Among authors: bueren ja. Gene Ther. 2004 Mar;11(5):474-82. doi: 10.1038/sj.gt.3302188. Gene Ther. 2004. PMID: 14724690

7

Genetic modification of hematopoietic stem cells: recent advances in the gene therapy of inherited diseases.

Bueren JA, Guenechea G, Casado JA, Lamana ML, Segovia JC. Bueren JA, et al. Arch Med Res. 2003 Nov-Dec;34(6):589-99. doi: 10.1016/j.arcmed.2003.09.004. Arch Med Res. 2003. PMID: 14734099 Review.

8

Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.

Yañez R, Lamana ML, García-Castro J, Colmenero I, Ramírez M, Bueren JA. Yañez R, et al. Among authors: bueren ja. Stem Cells. 2006 Nov;24(11):2582-91. doi: 10.1634/stemcells.2006-0228. Epub 2006 Jul 27. Stem Cells. 2006. PMID: 16873762

9

Characteristics of lentiviral vectors harboring the proximal promoter of the vav proto-oncogene: a weak and efficient promoter for gene therapy.

Almarza E, Río P, Meza NW, Aldea M, Agirre X, Guenechea G, Segovia JC, Bueren JA. Almarza E, et al. Among authors: bueren ja. Mol Ther. 2007 Aug;15(8):1487-94. doi: 10.1038/sj.mt.6300213. Epub 2007 May 29. Mol Ther. 2007. PMID: 17534266 Free article.

10

Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients.

Jacome A, Navarro S, Río P, Yañez RM, González-Murillo A, Lozano ML, Lamana ML, Sevilla J, Olive T, Diaz-Heredia C, Badell I, Estella J, Madero L, Guenechea G, Casado J, Segovia JC, Bueren JA. Jacome A, et al. Among authors: bueren ja. Mol Ther. 2009 Jun;17(6):1083-92. doi: 10.1038/mt.2009.26. Epub 2009 Mar 10. Mol Ther. 2009. PMID: 19277017 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page